- Home
- BHE vs NEO Comparison
BHE vs NEO Comparison
Compare BHE & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHE
- NEO
- Stock Information
- Founded
- BHE 1979
- NEO 2001
- Country
- BHE United States
- NEO United States
- Employees
- BHE N/A
- NEO N/A
- Industry
- BHE Electrical Products
- NEO Precision Instruments
- Sector
- BHE Technology
- NEO Health Care
- Exchange
- BHE Nasdaq
- NEO Nasdaq
- Market Cap
- BHE 1.2B
- NEO 1.2B
- IPO Year
- BHE 1990
- NEO 1999
- Fundamental
- Price
- BHE $36.76
- NEO $9.91
- Analyst Decision
- BHE Strong Buy
- NEO Strong Buy
- Analyst Count
- BHE 3
- NEO 10
- Target Price
- BHE $43.00
- NEO $19.44
- AVG Volume (30 Days)
- BHE 335.4K
- NEO 1.8M
- Earning Date
- BHE 05-05-2025
- NEO 04-29-2025
- Dividend Yield
- BHE 1.85%
- NEO N/A
- EPS Growth
- BHE N/A
- NEO N/A
- EPS
- BHE 1.72
- NEO N/A
- Revenue
- BHE $2,656,105,000.00
- NEO $660,566,000.00
- Revenue This Year
- BHE $4.55
- NEO $13.06
- Revenue Next Year
- BHE $7.17
- NEO $11.18
- P/E Ratio
- BHE $21.38
- NEO N/A
- Revenue Growth
- BHE N/A
- NEO 11.65
- 52 Week Low
- BHE $29.52
- NEO $8.05
- 52 Week High
- BHE $52.57
- NEO $19.11
- Technical
- Relative Strength Index (RSI)
- BHE 49.62
- NEO 53.04
- Support Level
- BHE $34.38
- NEO $9.30
- Resistance Level
- BHE $35.97
- NEO $10.18
- Average True Range (ATR)
- BHE 1.91
- NEO 0.70
- MACD
- BHE 0.26
- NEO 0.18
- Stochastic Oscillator
- BHE 83.29
- NEO 77.82
About BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and advanced manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.